Remidio - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2009, Remidio operates in Health Tech industry. Initially focusing on portable and affordable retinal imaging devices, the company has evolved to incorporate artificial intelligence in its ...
Funding stage:
Corporate Round
Last funding:
18/02/2023
Total funding:
$18.11 Mn+
Revenue:
Investors
Employee count:
221
Last 90d
221
Last 90d
Web traffic:
10.72K
10.72K
Last 30d
Last 30d
Glassdoor Rating:
Remidio: Funding Highlights
Funding highlights of Remidio and a snapshot of its key metrics.
Total Funding$18.11 Mn+
Current StageGrowth Stage
Total Round(s)2
Funding Rounds
FAQs on Funding of Remidio
Health Tech Funded Remidio has raised a total funding of $18.11 million as of 19 February 2023 across 2 rounds. Find the details around funding rounds, participating investors, and other insights of Remidio here...
Remidio has raised a total of $18.11 million across 2 funding rounds and the last round was raised on 19 February 2023.
Remidio's key investors include Cipher Plexus and Sun Pharmaceutical Industries.
Remidio's latest funding round was $18.11 million in Growth Stage, raised on 19 February 2023.
Remidio is at the Growth stage. Its most recent round was raised on 19 February 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links